Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

North China Pharmaceutical Co Ltd Announces Positive Result of Phase I Clinical Trial


Monday, 21 Oct 2013 08:00pm EDT 

North China Pharmaceutical Co Ltd announced that it has completed the phase I clinical trial for the human anti-rabies virus antibody injection and the result is positive. The Company will start the phase II clinical trial soon. 

Company Quote

6.65
-0.04 -0.60%
28 Nov 2014